...stage example was Roche’s July deal that gave it an option to acquire remyelination company Convelo Therapeutics Inc....

..."Roche Broadens its BD Scope" ). MS is a focus of Genentech Inc.'s partnership with Convelo Therapeutics Inc....
...GPCR - G protein-coupled receptor; TM7SF2 - Transmembrane 7 superfamily member 2 Elizabeth S. Eaton, Staff Writer Convelo Therapeutics Inc. Genentech...

...Derrick Rossi, a co-founder of Intellia Therapeutics Inc. who is now CEO of remyelination company Convelo Therapeutics Inc....
...their interest in mitochondrial gene editing. Companies and Institutions Mentioned Cellectis S.A. (NASDAQ:CLLS), Paris, France Convelo Therapeutics Inc....

...multiple sclerosis targets, according to a group at Case Western. The university is spinning out Convelo Therapeutics Inc....
...Development status Preclinical Patents Patent applications submitted by Case Western Reserve University and licensed to Convelo Therapeutics Inc....
...investigator Convelo Therapeutics; Derrick Rossi Companies and Institutions Mentioned Case Western Reserve University, Cleveland, Ohio Convelo therapeutics Inc....

...screening systems, remyelination platforms and candidates. Convelo Therapeutics Inc., Cleveland, Ohio Business: Neurology, Autoimmune Chris Lieu Case Western Reserve University Convelo Therapeutics Inc. Multiple...